News
-
-
-
REGULATED PRESS RELEASE
bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
bioMérieux has acquired LUMED, a software company specializing in clinical decision support systems to optimize antimicrobial prescriptions and monitor healthcare-associated infections. This acquisition reinforces bioMérieux's commitment to combat antimicrobial resistance and improve infection prevention and control through advanced software solutions. -
-
-
REGULATED PRESS RELEASE
bioMérieux – Information financière du 3ème trimestre 2023
-
REGULATED PRESS RELEASE
bioMérieux – Third-Quarter 2023 Business Review
-
REGULATED PRESS RELEASE
bioMérieux makes strategic investment in Oxford Nanopore
-
REGULATED PRESS RELEASE
bioMérieux réalise un investissement stratégique dans Oxford Nanopore
-